newsfilter
← Latest News
GlobeNewswire·

Celyad Oncology to announce full year 2022 financial results and host conference call

MONT-SAINT-GUIBERT, Belgium, March 17, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology ((Euronext &, NASDAQ:CYAD) (the "Company"), a biotechnology company focused on the discovery and development of innovative technologies